Disruption of the p53-p21 pathway inhibits efficiency of the lytic-replication cycle of herpes simplex virus type 2 (HSV-2)

Virus Research

Volumn 169, Issue 1, 2012, Pages 91-97

  Zhou, Qi ^a   Zhu, Meng ^a   Zhang, Hao ^a   Yi, Ting ^b   Klena, John D ^a   Peng, Yihong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b The People's Hospital of Yichun City   (China)

Author keywords

HSV 2; P21; P53; SiRNAs; Viral replication

Indexed keywords

BETA ACTIN; GLYCOPROTEIN B; NUCLEOTIDE; PROTEIN P21; PROTEIN P53; SERINE; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA MARKER; DNA SYNTHESIS; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84867206098     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.07.011     Document Type: Article

References (50)

1. Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nature Reviews Cancer 2009, 9:400-414.
2. Andrade A.A., Brasil B.S., Pereira A.C., Ferreira P.C., Kroon E.G., Bonjardim C.A. Vaccinia virus regulates expression of p21WAF1/Cip1 in A431 cells. Memorias do Instituto Oswaldo Cruz 2010, 105:269-277.
3. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. European Journal of Biochemistry 2001, 268:2764-2772.
4. Aubert M., Blaho J.A. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. Journal of Virology 1999, 73:2803-2813.
5. Aubert M., Blaho J.A. Viral oncoapoptosis of human tumor cells. Gene Therapy 2003, 10(August (17)):1437-1445.
6. Boulaire J., Fotedar A., Fotedar R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathologie Biologie 2000, 48:190-202.
7. Boutell C., Everett R.D. Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner. Journal of Virology 2004, 78:8068-8077.
8. Capocefalo A., Franceschi V., Whitelaw C.B., Vasey D.B., Lillico S.G., Cavirani S., Donofrio G. p21(Waf1/Cip1) as a molecular sensor for BoHV-4 replication. Journal of Virological Methods 2009, 161:308-311.
9. Cayrol C., Flemington E. G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. Journal of Biological Chemistry 1996, 271:31799-31802.
10. Durand L.O., Advani S.J., Poon A.P., Roizman B. The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1. Journal of Virology 2005, 79:6757-6762.
11. Ehmann G.L., McLean T.I., Bachenheimer S.L. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Virology 2000, 267:335-349.
12. Flemington E.K. Herpesvirus lytic replication and the cell cycle: arresting new developments. Journal of Virology 2001, 75:4475-4481.
13. Galvan V., Roizman B. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:931-936.
14. Gartel A.L., Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Research 2005, 65:3980-3985.
15. Gartel A.L., Tyner A.L. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Experimental Cell Research 1999, 246:280-289.
16. Giono L.E., Manfredi J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. Journal of Cellular Physiology 2006, 209:13-20.
17. Han J.Y., Miller S.A., Wolfe T.M., Pourhassan H., Jerome K.R. Cell type-specific induction and inhibition of apoptosis by herpes simplex virus type 2 ICP10. Journal of Virology 2009, 83:2765-2769.
18. Han Z., Wei W., Dunaway S., Darnowski J.W., Calabresi P., Sedivy J., Hendrickson E.A., Balan K.V., Pantazis P., Wyche J.H. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. Journal of Biological Chemistry 2002, 277:17154-17160.
19. Hayashi M.L., Blankenship C., Shenk T. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:2692-2696.
20. He Y., Xu K., Keiner B., Zhou J., Czudai V., Li T., Chen Z., Liu J., Klenk H.D., Shu Y.L., Sun B. Influenza A virus replication induces cell cycle arrest in G0/G1 phase. Journal of Virology 2010, 84:12832-12840.
21. Hobbsand W.E., DeLuca N.A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. Journal of Virology 1999, 73:8245-8255.
22. Huang S.Y., Hsieh M.J., Chen C.Y., Chen Y.J., Chen J.Y., Chen M.R., Tsai C.H., Lin S.F., Hsu T.Y. Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma arrests cells at the G1/S transition by reducing cyclin E/CDK2 activity. Journal of General Virology 2012, 93:139-149.
23. Jabbur J.R., Huang P., Zhang W. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo. Oncogene 2000, 19:6203-6208.
24. Jung Y.S., Qian Y., Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cellular Signalling 2010, 22:1003-1012.
25. Kalejta R.F., Shenk T. Manipulation of the cell cycle by human cytomegalovirus. Frontiers in Bioscience 2002, 7:d295-d306.
26. Katsura T., Iwai S., Ota Y., Shimizu H., Ikuta K., Yura Y. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. Cancer Gene Therapy 2009, 16:237-245.
27. Kim E., Deppert W. The complex interactions of p53 with target DNA: we learn as we go. Biochemistry and Cell Biology 2003, 81:141-150.
28. Kohno M., Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Annals of Medicine 2006, 38:200-211.
29. Koyama A.H., Adachi A. Induction of apoptosis by herpes simplex virus type 1. Journal of General Virology 1997, 78(Pt 11):2909-2912.
30. Koyama A.H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. Journal of Virology 1997, 71:2567-2571.
31. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
32. Lomonte P., Everett R.D. Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. Journal of Virology 1999, 73:9456-9467.
33. Ludwig S. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biological Chemistry 2011, 392:837-847.
34. Munoz-Fontela C., Garcia M.A., Garcia-Cao I., Collado M., Arroyo J., Esteban M., Serrano M., Rivas C. Resistance to viral infection of super p53 mice. Oncogene 2005, 24:3059-3062.
35. Munoz-Fontela C., Macip S., Martinez-Sobrido L., Brown L., Ashour J., Garcia-Sastre A., Lee S.W., Aaronson S.A. Transcriptional role of p53 in interferon-mediated antiviral immunity. Journal of Experimental Medicine 2008, 205:1929-1938.
36. Nguyen M.L., Blaho J.A. Cellular players in the herpes simplex virus dependent apoptosis balancing act. Viruses 2009, 1:965-978.
37. Oster B., Kofod-Olsen E., Bundgaard B., Hollsberg P. Restriction of human herpesvirus 6B replication by p53. Journal of General Virology 2008, 89:1106-1113.
38. Pan D., Pan L.Z., Hill R., Marcato P., Shmulevitz M., Vassilev L.T., Lee P.W. Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-kappaB activation. British Journal of Cancer 2011, 105:1012-1022.
39. Raj K., Ogston P., Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001, 412:914-917.
40. Sanfilippo C.M., Blaho J.A. ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger. Journal of Virology 2006, 80:6810-6821.
41. Shieh S.Y., Taya Y., Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO Journal 1999, 18:1815-1823.
42. Siakallis G., Spandidos D.A., Sourvinos G. Herpesviridae and novel inhibitors. Antiviral Therapy 2009, 14:1051-1064.
43. Thompson T., Tovar C., Yang H., Carvajal D., Vu B.T., Xu Q., Wahl G.M., Heimbrook D.C., Vassilev L.T. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. Journal of Biological Chemistry 2004, 279:53015-53022.
44. Turpin E., Luke K., Jones J., Tumpey T., Konan K., Schultz-Cherry S. Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. Journal of Virology 2005, 79:8802-8811.
45. Weir J.P. Regulation of herpes simplex virus gene expression. Gene 2001, 271:117-130.
46. Whitley R. Neonatal herpes simplex virus infection. Current Opinion in Infectious Diseases 2004, 17:243-246.
47. Wiebusch L., Hagemeier C. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). Journal of Virology 1999, 73:9274-9283.
48. Wilson S.S., Fakioglu E., Herold B.C. Novel approaches in fighting herpes simplex virus infections. Expert Review of Anti-Infective Therapy 2009, 7:559-568.
49. Wu W., Munday D.C., Howell G., Platt G., Barr J.N., Hiscox J.A. Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells. Journal of Virology 2011, 85:10300-10309.
50. Zhang H., Feng H., Luo L., Zhou Q., Luo Z., Peng Y. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Research 2010, 150:22-27.